To establish eligibility of patients with heart failure and reduced ejection fraction for treatment with Sacubitril/Valsartan in the Swedish Heart Failure registry
Latest Information Update: 06 Apr 2020
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 22 Dec 2016 New trial record
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association